205 related articles for article (PubMed ID: 33236786)
1. SCN2A-Developmental and Epileptic Encephalopathies: Challenges to trial-readiness for non-seizure outcomes.
Berg AT; Palac H; Wilkening G; Zelko F; Schust Meyer L
Epilepsia; 2021 Jan; 62(1):258-268. PubMed ID: 33236786
[TBL] [Abstract][Full Text] [Related]
2. Rare diseases - rare outcomes: Assessing communication abilities for the developmental and epileptic encephalopathies.
Berg AT; Kaat AJ; Zelko F; Wilkening G
Epilepsy Behav; 2022 Mar; 128():108586. PubMed ID: 35158285
[TBL] [Abstract][Full Text] [Related]
3. Biological concepts in human sodium channel epilepsies and their relevance in clinical practice.
Brunklaus A; Du J; Steckler F; Ghanty II; Johannesen KM; Fenger CD; Schorge S; Baez-Nieto D; Wang HR; Allen A; Pan JQ; Lerche H; Heyne H; Symonds JD; Zuberi SM; Sanders S; Sheidley BR; Craiu D; Olson HE; Weckhuysen S; DeJonge P; Helbig I; Van Esch H; Busa T; Milh M; Isidor B; Depienne C; Poduri A; Campbell AJ; Dimidschstein J; Møller RS; Lal D
Epilepsia; 2020 Mar; 61(3):387-399. PubMed ID: 32090326
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal assessment of adaptive behavior in infants and young children with newly diagnosed epilepsy: influences of etiology, syndrome, and seizure control.
Berg AT; Smith SN; Frobish D; Beckerman B; Levy SR; Testa FM; Shinnar S
Pediatrics; 2004 Sep; 114(3):645-50. PubMed ID: 15342834
[TBL] [Abstract][Full Text] [Related]
5. The phenotype and treatment of SCN2A-related developmental and epileptic encephalopathy.
Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
Epileptic Disord; 2020 Oct; 22(5):563-570. PubMed ID: 33000761
[TBL] [Abstract][Full Text] [Related]
6. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
Wolff M; Johannesen KM; Hedrich UBS; Masnada S; Rubboli G; Gardella E; Lesca G; Ville D; Milh M; Villard L; Afenjar A; Chantot-Bastaraud S; Mignot C; Lardennois C; Nava C; Schwarz N; Gérard M; Perrin L; Doummar D; Auvin S; Miranda MJ; Hempel M; Brilstra E; Knoers N; Verbeek N; van Kempen M; Braun KP; Mancini G; Biskup S; Hörtnagel K; Döcker M; Bast T; Loddenkemper T; Wong-Kisiel L; Baumeister FM; Fazeli W; Striano P; Dilena R; Fontana E; Zara F; Kurlemann G; Klepper J; Thoene JG; Arndt DH; Deconinck N; Schmitt-Mechelke T; Maier O; Muhle H; Wical B; Finetti C; Brückner R; Pietz J; Golla G; Jillella D; Linnet KM; Charles P; Moog U; Õiglane-Shlik E; Mantovani JF; Park K; Deprez M; Lederer D; Mary S; Scalais E; Selim L; Van Coster R; Lagae L; Nikanorova M; Hjalgrim H; Korenke GC; Trivisano M; Specchio N; Ceulemans B; Dorn T; Helbig KL; Hardies K; Stamberger H; de Jonghe P; Weckhuysen S; Lemke JR; Krägeloh-Mann I; Helbig I; Kluger G; Lerche H; Møller RS
Brain; 2017 May; 140(5):1316-1336. PubMed ID: 28379373
[TBL] [Abstract][Full Text] [Related]
7. What does better look like in individuals with severe neurodevelopmental impairments? A qualitative descriptive study on SCN2A-related developmental and epileptic encephalopathy.
Downs J; Ludwig NN; Wojnaroski M; Keeley J; Schust Myers L; Chapman CAT; Hecker J; Conecker G; Berg AT
Qual Life Res; 2024 Feb; 33(2):519-528. PubMed ID: 38064015
[TBL] [Abstract][Full Text] [Related]
8. Relationship of electrophysiological dysfunction and clinical severity in SCN2A-related epilepsies.
Lauxmann S; Verbeek NE; Liu Y; Zaichuk M; Müller S; Lemke JR; van Kempen MJA; Lerche H; Hedrich UBS
Hum Mutat; 2018 Dec; 39(12):1942-1956. PubMed ID: 30144217
[TBL] [Abstract][Full Text] [Related]
9. Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes.
Begemann A; Acuña MA; Zweier M; Vincent M; Steindl K; Bachmann-Gagescu R; Hackenberg A; Abela L; Plecko B; Kroell-Seger J; Baumer A; Yamakawa K; Inoue Y; Asadollahi R; Sticht H; Zeilhofer HU; Rauch A
Mol Med; 2019 Feb; 25(1):6. PubMed ID: 30813884
[TBL] [Abstract][Full Text] [Related]
10. Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies.
Zhou P; He N; Zhang JW; Lin ZJ; Wang J; Yan LM; Meng H; Tang B; Li BM; Liu XR; Shi YW; Zhai QX; Yi YH; Liao WP
Genes Brain Behav; 2018 Nov; 17(8):e12456. PubMed ID: 29314583
[TBL] [Abstract][Full Text] [Related]
11. Measuring the inch stones for progress: Gross motor function in the developmental and epileptic encephalopathies.
Berg AT; Kaat AJ; Gaebler-Spira D
Epilepsy Behav; 2022 Dec; 137(Pt A):108953. PubMed ID: 36368092
[TBL] [Abstract][Full Text] [Related]
12. The phenotypic spectrum of SCN2A-related epilepsy.
Reynolds C; King MD; Gorman KM
Eur J Paediatr Neurol; 2020 Jan; 24():117-122. PubMed ID: 31924505
[TBL] [Abstract][Full Text] [Related]
13. SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures.
Howell KB; McMahon JM; Carvill GL; Tambunan D; Mackay MT; Rodriguez-Casero V; Webster R; Clark D; Freeman JL; Calvert S; Olson HE; Mandelstam S; Poduri A; Mefford HC; Harvey AS; Scheffer IE
Neurology; 2015 Sep; 85(11):958-66. PubMed ID: 26291284
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Core Features in Four Developmental Encephalopathies in the Rett Natural History Study.
Cutri-French C; Armstrong D; Saby J; Gorman C; Lane J; Fu C; Peters SU; Percy A; Neul JL; Marsh ED
Ann Neurol; 2020 Aug; 88(2):396-406. PubMed ID: 32472944
[TBL] [Abstract][Full Text] [Related]
15. Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of
Berecki G; Howell KB; Deerasooriya YH; Cilio MR; Oliva MK; Kaplan D; Scheffer IE; Berkovic SF; Petrou S
Proc Natl Acad Sci U S A; 2018 Jun; 115(24):E5516-E5525. PubMed ID: 29844171
[TBL] [Abstract][Full Text] [Related]
16. Adaptive behavior in autism: Minimal clinically important differences on the Vineland-II.
Chatham CH; Taylor KI; Charman T; Liogier D'ardhuy X; Eule E; Fedele A; Hardan AY; Loth E; Murtagh L; Del Valle Rubido M; San Jose Caceres A; Sevigny J; Sikich L; Snyder L; Tillmann JE; Ventola PE; Walton-Bowen KL; Wang PP; Willgoss T; Bolognani F
Autism Res; 2018 Feb; 11(2):270-283. PubMed ID: 28941213
[TBL] [Abstract][Full Text] [Related]
17. Vineland adaptive behavior scales to identify neurodevelopmental problems in children with Congenital Hyperinsulinism (CHI).
Salomon-Estebanez M; Mohamed Z; Michaelidou M; Collins H; Rigby L; Skae M; Padidela R; Rust S; Dunne M; Cosgrove K; Banerjee I; Nicholson J
Orphanet J Rare Dis; 2017 May; 12(1):96. PubMed ID: 28532504
[TBL] [Abstract][Full Text] [Related]
18. [Phenotype study of SCN2A gene related epilepsy].
Zeng Q; Zhang YH; Yang XL; Zhang J; Liu AJ; Liu XY; Jiang YW; Wu XR
Zhonghua Er Ke Za Zhi; 2018 Jul; 56(7):518-523. PubMed ID: 29996185
[No Abstract] [Full Text] [Related]
19. Ketogenic diet as a successful early treatment modality for SCN2A mutation.
Turkdogan D; Thomas G; Demirel B
Brain Dev; 2019 Apr; 41(4):389-391. PubMed ID: 30415926
[TBL] [Abstract][Full Text] [Related]
20. Dystonia as a prominent presenting feature in developmental and epileptic encephalopathies: A case series.
Dzinovic I; Škorvánek M; Necpál J; Boesch S; Švantnerová J; Wagner M; Havránková P; Pavelekova P; Haň V; Janzarik WG; Berweck S; Diebold I; Kuster A; Jech R; Winkelmann J; Zech M
Parkinsonism Relat Disord; 2021 Sep; 90():73-78. PubMed ID: 34399161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
